Fed's Mussallem: Growth to be Below Trend, Inflation Risks to Rise
According to Golden Ten, the Fed's Mussallem said US economic growth could fall ‘sharply’ below trend, and that the unemployment rate will rise over the year as businesses and households adjust to prices pushed up by new import tariffs.
I don't have a baseline for a recession, but I think growth could be well below trend," Mussallem said, estimating growth at around 2 per cent.
‘There are risks in both directions that will materialise,’ he said, with higher-than-expected tariffs putting pressure on prices, falling confidence and the recent sharp fall in the stock market likely to dampen spending, hitting household wealth, and price rises set to take their toll, which together will lead to slower growth. Mussallem, who has a vote on interest rate policy this year, said the response of monetary policy will depend on how inflation and unemployment evolve in the coming months, whether price shocks persist and whether inflation expectations are in line with the Fed's 2 per cent inflation target.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Oil and AI chip imports drive U.S. August trade deficit to expand to 105.6 billions, reaching a 17-month high
The U.S. trade deficit widened to $105.6 billion in August, reaching its highest level since March 2025, with imports hitting a record $420.8 billion. This surge was mainly driven by a significant rise in semiconductor and capital goods imports due to AI data center construction. The larger-than-expected deficit led Goldman Sachs and the Atlanta Fed to lower their third-quarter GDP forecasts.
The New Zealand Dollar edges off its low as the US Dollar slips
Encompass Health Opens Rehabilitation Hospital in Bangor, Maine
05:57 PM EDT, 10/06/2026 (MT Newswires) -- Encompass Health (EHC) said late Tuesday it has opened the Encompass Health Rehabilitation Hospital of Bangor in Bangor, Maine and the 50-bed inpatient rehabilitation hospital is now accepting patients. The hospital offers essential rehabilitation services to help patients recovering from strokes, brain injuries, spinal cord injuries, amputations and complex orthopedic conditions regain functional ability, independence and quality of life, the company said. Patients receive physical, occupational and speech therapy based on their individual needs.
Constellation Brands, the maker of Corona beer, exceeds market expectations in the second quarter thanks to strong demand
Reuters, October 6 - Constellation Brands (STZ.N) reported on Tuesday that its second-quarter profit and sales both exceeded market expectations, thanks to strong demand for its beer products such as Modelo Especial and Victoria, which effectively offset challenges facing the alcohol sector amid weak consumer sentiment. The company also announced that it had acquired SpikedAde, a ready-to-drink (RTD) company with vodka-based products, for at least $75 million, as part of its strategy to expand into new demand segments and strengthen its position in the fast-growing RTD category. Constellation Brands will pay $75 million upon the closing of the SpikedAde deal, and up to an additional $278 million over the next five years, depending on the brand’s performance and the company’s capital allocation priorities. The company’s beer business benefited this year from major sports events, as the FIFA World Cup and NBA Finals boosted viewing parties and social drinking occasions. According to data compiled by London Stock Exchange Group (LSEG), net sales for the quarter ended August 31 rose 6% to $2.63 billion, surpassing analysts’ average estimate of $2.54 billion. Adjusted earnings per share for the quarter were $3.74, above the expected $3.56. The wine and spirits business reported quarterly net sales growth of 17%, while beer increased by 5%. Constellation Brands reaffirmed its fiscal 2027 performance outlook: adjusted earnings per share between $11.20 and $11.90, with organic net sales expected to range from a 1% decline to a 1% increase. The company lowered its annual operating margin forecast from the previous 32%-33% range to between 31% and 32%. Its stock fell 4.5% in after-hours trading, with a year-to-date drop of about 16%. In April, the company withdrew its fiscal 2028 performance outlook, citing a turbulent operating environment and uncertain near-term prospects.